Clinical Trial Criteria

Trial ID: NCT07062263
Title: HER2+ Biliary Cancer Treatment Study

Inclusion Criteria:
- Age ≥ 18 years
- HER2 positive status confirmed by IHC/ISH
- Histologically confirmed biliary cancer
- ECOG performance status ≤ 2
- Adequate organ function

Exclusion Criteria:
- CNS metastases
- Prior HER2-targeted therapy
- Pregnancy or breastfeeding
- Active infection requiring treatment

Required Tests:
- HER2 immunohistochemistry
- Complete blood count (CBC)
- Liver function tests
- Imaging studies (CT/MRI)
